Canaccord lowered the firm’s price target on Illumina (ILMN) to $92 from $115 and keeps a Hold rating on the shares. The firm said its target decrease reflects multiple headwinds including tariffs, funding uncertainty, recession fears, and China.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- BTIG Analyst Sees Tempus AI (TEM) as “Significant Free Call Option” with 48% Upside
- Illumina price target lowered to $90 from $130 at Bernstein
- Illumina and Tempus AI partner for AI application in precision medicine
- Illumina price target lowered to $75 from $90 at BofA
- Illumina price target lowered to $77 from $100 at Barclays